Trisalus Life Sciences Inc (TLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | 09-2020 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 1,129 | N/A | 0 |
| TOTAL | $1,757 | $N/A | $0 |
| Non-Current Assets | |||
| Investments And Advances | 250,038 | 0 | 0 |
| TOTAL | $250,038 | $N/A | $N/A |
| Total Assets | $251,795 | $N/A | $0 |
| Liabilities | |||
| Current Liabilities | |||
| Accrued Expenses | 160 | N/A | 0 |
| TOTAL | $160 | $N/A | $0 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 237,885 | 0 | 0 |
| TOTAL | $246,635 | $N/A | $N/A |
| Total Liabilities | $246,795 | $N/A | $0 |
| Shareholders' Equity | |||
| Shares Outstanding, K | 31,250 | N/A | N/A |
| Common Shares | 1 | N/A | 0 |
| Retained earnings | -1,083 | N/A | 0 |
| TOTAL | $5,000 | $N/A | $0 |
| Total Liabilities And Equity | $251,795 | $0 | $0 |